Topics

Articles

Industry consortium is poised to manage pharma supply-chain interoperability governance

Quarles & Brady garners an innovative distinction

Strains are showing in drug supplies consumed in treating infected patients

Production quotas for controlled substances are being raised by 15%

Newly initiated trials may prove value—but even then, supplies may be limited, and hoarding is already occurring

DEA-registered practitioners can prescribe without an in-person interview

Guidance enables these workers to continue reporting to work

Now two-plus years on, the dispute over physician databases shows no sign of resolution

Too many states have opted out of the $18-billion agreement being negotiated in federal court

Of NDA/BLA drugs, 45% require cold-chain distribution